To include your compound in the COVID-19 Resource Center, submit it here.
The French Health Ministry said a Phase I trial of the oral analgesic BIA 10-2474 from Bial-Portela & Ca. S.A. (S. Mamede do
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury